C928-010: An Open- Label, Dose Escalation Study to Assess the Safety, Pharmacokinetics andPharmacodynamic Signals of DUR-928 in Patients with Alcoholic Hepatitis

Project: Research project

Project Details

Description

C928-010: An Open- Label, Dose Escalation Study to Assess the Safety, Pharmacokinetics and Pharmacodynamic Signals of DUR-928 in Patients with Alcoholic Hepatitis
StatusFinished
Effective start/end date10/24/183/31/19

Funding

  • DURECT CORPORATION

Fingerprint Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.